Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 820 of 1,261

  1. US 8703727

    Nanotechnology formulation of poorly soluble compounds

    Aphios Corporation · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  2. US 8703726

    Methods for treating prostate conditions

    PTC THERAPEUTICS, INC. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  3. US 8703208

    Nanometer mesoporous silica-based xerogel styptic process and its preparing process and application

    East China University of Science and Technology · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  4. US 8703762

    Method of treating organophosphorous poisoning

    The United States of America as repr. by the Sec. of the Army, U.S. Army Med. Resr. Inst. of Chem. Defense · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  5. US 8703751

    Androstenediol as an indicator for assessing estrogenicity

    The Regents of the University of California · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  6. US 8703730

    Complement antagonists and uses thereof

    REGENESANCE B.V. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  7. US 8703921

    Compositions and methods for delivering inhibitory oligonucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  8. US 8703096

    Beta-amyloid PET imaging agents

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  9. US 8703758

    Bicyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  10. US 8703840

    Dental adhesive material kit

    KURARAY NORITAKE DENTAL INC. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  11. US 8703987

    Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile)copper(I) tetrafluoroborate

    Draximage Limited · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  12. US 8703150

    Methods of using Bacillus anthracis protective antigen sequences for vaccination

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  13. US 8703192

    Dosage form containing pantoprazole as active ingredient

    TAKEDA GMBH · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  14. US 8703098

    Labelled adrenomedullin derivatives and their use for imaging and therapy

    INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  15. CA 2883399

    REDUCTION AU MINIMUM DE DEPOTS LIPIDIQUES BIOLOGIQUES SUR DES LENTILLES DE CONTACT

    BAUSCH & LOMB [US] · Granted Apr 17, 2014 · Expires Apr 12, 2034

    granted

  16. US 8697704

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  17. US 8697744

    Substituted 5,6-dihydro-4H-thiazolo[4,5-E]indazoles and their use as positive allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  18. US 8697644

    Stable formulations for parenteral injection of peptide drugs

    XERIS PHARMACEUTICALS, INC. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  19. US 8697375

    In vivo biofilm infection diagnosis and treatment

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  20. US 8697836

    Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response

    The Regents of the University of California · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  21. US 8697387

    Methods for identifying agents and their use for the prevention of restenosis

    DISCOVERX CORPORATION · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  22. US 8697082

    Prevention and treatment of synucleinopathic and amyloidogenic disease

    The Regents of the University of California · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  23. US 8697081

    Method of modulating neovascularization

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  24. US 8697130

    Non-irritating benzoyl peroxide

    Essential Ingredients, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.